Selected research
Industry Research
Digital Chronic Disease Management Industry Research Report 2026
Market perspective
The global Digital Chronic Disease Management market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Digital Chronic Disease Management market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Digital Chronic Disease Management market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Digital Chronic Disease Management market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Digital Chronic Disease Management include S3 Connected Health, WellDoc, AstraZeneca, NTT DATA, Credo Health Services, Dawn Health, Bayer, Medtronic and Teladoc Health, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Digital Chronic Disease Management market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Digital Chronic Disease Management.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Digital Chronic Disease Management Market by Company
S3 Connected Health
WellDoc
AstraZeneca
NTT DATA
Credo Health Services
Dawn Health
Bayer
Medtronic
Teladoc Health
ScienceSoft
TriZetto Healthcare (Cognizant)
Omada Health
Phable
Pack Health
Epic Systems
Pathmate
EveryDose
Aptar Digital Health
VITech
ClouDr Group
JD Health
Ali Health
Ping An Good Doctor
We Doctor Group
Wei Mai
Medlinker
Digital Chronic Disease Management Segment by Type
Charge
Free
Digital Chronic Disease Management Segment by Application
Medical Institutions
Pharmacy
Chronic Disease Patients
Digital Chronic Disease Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Chronic Disease Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Digital Chronic Disease Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Chronic Disease Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Digital Chronic Disease Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
List of Tables
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
Table 5. Global Digital Chronic Disease Management Market Size by Type (2021-2026) & (US$ Million)
Table 6. Global Digital Chronic Disease Management Revenue Market Share by Type (2021-2026)
Table 7. Global Digital Chronic Disease Management Forecasted Market Size by Type (2027-2032) & (US$ Million)
Table 8. Global Digital Chronic Disease Management Revenue Market Share by Type (2027-2032)
Table 9. Global Digital Chronic Disease Management Market Size by Application (2021-2026) & (US$ Million)
Table 10. Global Digital Chronic Disease Management Revenue Market Share by Application (2021-2026)
Table 11. Global Digital Chronic Disease Management Forecasted Market Size by Application (2027-2032) & (US$ Million)
Table 12. Global Digital Chronic Disease Management Revenue Market Share by Application (2027-2032)
Table 13. Global Digital Chronic Disease Management Market Size by Region (US$ Million): 2021 VS 2025 VS 2032
Table 14. Global Digital Chronic Disease Management Market Size by Region (2021-2026) & (US$ Million)
Table 15. Global Digital Chronic Disease Management Market Share by Region (2021-2026)
Table 16. Global Digital Chronic Disease Management Forecasted Market Size by Region (2027-2032) & (US$ Million)
Table 17. Global Digital Chronic Disease Management Market Share by Region (2027-2032)
Table 18. Digital Chronic Disease Management Industry Trends
Table 19. Digital Chronic Disease Management Industry Drivers
Table 20. Digital Chronic Disease Management Industry Opportunities and Challenges
Table 21. Digital Chronic Disease Management Market Restraints
Table 22. Global Top Digital Chronic Disease Management Players by Revenue (US$ Million) & (2021-2026)
Table 23. Global Digital Chronic Disease Management Revenue Market Share by Players (2021-2026)
Table 24. Global Digital Chronic Disease Management Industry Players Ranking, 2024 VS 2025 VS 2026
Table 25. Global Key Players of Digital Chronic Disease Management, Headquarters and Area Served
Table 26. Global Digital Chronic Disease Management Players, Product Type & Application
Table 27. Global Players Market Concentration Ratio (CR5 and HHI)
Table 28. Global Digital Chronic Disease Management by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025)
Table 29. Players Mergers & Acquisitions, Expansion Plans
Table 30. North America Digital Chronic Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 31. North America Digital Chronic Disease Management Market Size by Country (2021-2026) & (US$ Million)
Table 32. North America Digital Chronic Disease Management Market Size by Country (2027-2032) & (US$ Million)
Table 33. Europe Digital Chronic Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 34. Europe Digital Chronic Disease Management Market Size by Country (2021-2026) & (US$ Million)
Table 35. Europe Digital Chronic Disease Management Market Size by Country (2027-2032) & (US$ Million)
Table 36. Asia Pacific Digital Chronic Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 37. Asia Pacific Digital Chronic Disease Management Market Size by Region (2021-2026) & (US$ Million)
Table 38. Asia Pacific Digital Chronic Disease Management Market Size by Country (2027-2032) & (US$ Million)
Table 39. South America Digital Chronic Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 40. South America Digital Chronic Disease Management Market Size by Country (2021-2026) & (US$ Million)
Table 41. South America Digital Chronic Disease Management Market Size by Country (2027-2032) & (US$ Million)
Table 42. Middle East & Africa Digital Chronic Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million)
Table 43. Middle East & Africa Digital Chronic Disease Management Market Size by Country (2021-2026) & (US$ Million)
Table 44. Middle East & Africa Digital Chronic Disease Management Market Size by Country (2027-2032) & (US$ Million)
Table 45. S3 Connected Health Company Information
Table 46. S3 Connected Health Business Overview
Table 47. S3 Connected Health Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 48. S3 Connected Health Digital Chronic Disease Management Product Portfolio
Table 49. S3 Connected Health Recent Developments
Table 50. WellDoc Company Information
Table 51. WellDoc Business Overview
Table 52. WellDoc Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 53. WellDoc Digital Chronic Disease Management Product Portfolio
Table 54. WellDoc Recent Developments
Table 55. AstraZeneca Company Information
Table 56. AstraZeneca Business Overview
Table 57. AstraZeneca Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 58. AstraZeneca Digital Chronic Disease Management Product Portfolio
Table 59. AstraZeneca Recent Developments
Table 60. NTT DATA Company Information
Table 61. NTT DATA Business Overview
Table 62. NTT DATA Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 63. NTT DATA Digital Chronic Disease Management Product Portfolio
Table 64. NTT DATA Recent Developments
Table 65. Credo Health Services Company Information
Table 66. Credo Health Services Business Overview
Table 67. Credo Health Services Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 68. Credo Health Services Digital Chronic Disease Management Product Portfolio
Table 69. Credo Health Services Recent Developments
Table 70. Dawn Health Company Information
Table 71. Dawn Health Business Overview
Table 72. Dawn Health Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 73. Dawn Health Digital Chronic Disease Management Product Portfolio
Table 74. Dawn Health Recent Developments
Table 75. Bayer Company Information
Table 76. Bayer Business Overview
Table 77. Bayer Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 78. Bayer Digital Chronic Disease Management Product Portfolio
Table 79. Bayer Recent Developments
Table 80. Medtronic Company Information
Table 81. Medtronic Business Overview
Table 82. Medtronic Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 83. Medtronic Digital Chronic Disease Management Product Portfolio
Table 84. Medtronic Recent Developments
Table 85. Teladoc Health Company Information
Table 86. Teladoc Health Business Overview
Table 87. Teladoc Health Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 88. Teladoc Health Digital Chronic Disease Management Product Portfolio
Table 89. Teladoc Health Recent Developments
Table 90. ScienceSoft Company Information
Table 91. ScienceSoft Business Overview
Table 92. ScienceSoft Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 93. ScienceSoft Digital Chronic Disease Management Product Portfolio
Table 94. ScienceSoft Recent Developments
Table 95. TriZetto Healthcare (Cognizant) Company Information
Table 96. TriZetto Healthcare (Cognizant) Business Overview
Table 97. TriZetto Healthcare (Cognizant) Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 98. TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Portfolio
Table 99. TriZetto Healthcare (Cognizant) Recent Developments
Table 100. Omada Health Company Information
Table 101. Omada Health Business Overview
Table 102. Omada Health Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 103. Omada Health Digital Chronic Disease Management Product Portfolio
Table 104. Omada Health Recent Developments
Table 105. Phable Company Information
Table 106. Phable Business Overview
Table 107. Phable Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 108. Phable Digital Chronic Disease Management Product Portfolio
Table 109. Phable Recent Developments
Table 110. Pack Health Company Information
Table 111. Pack Health Business Overview
Table 112. Pack Health Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 113. Pack Health Digital Chronic Disease Management Product Portfolio
Table 114. Pack Health Recent Developments
Table 115. Epic Systems Company Information
Table 116. Epic Systems Business Overview
Table 117. Epic Systems Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 118. Epic Systems Digital Chronic Disease Management Product Portfolio
Table 119. Epic Systems Recent Developments
Table 120. Pathmate Company Information
Table 121. Pathmate Business Overview
Table 122. Pathmate Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 123. Pathmate Digital Chronic Disease Management Product Portfolio
Table 124. Pathmate Recent Developments
Table 125. EveryDose Company Information
Table 126. EveryDose Business Overview
Table 127. EveryDose Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 128. EveryDose Digital Chronic Disease Management Product Portfolio
Table 129. EveryDose Recent Developments
Table 130. Aptar Digital Health Company Information
Table 131. Aptar Digital Health Business Overview
Table 132. Aptar Digital Health Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 133. Aptar Digital Health Digital Chronic Disease Management Product Portfolio
Table 134. Aptar Digital Health Recent Developments
Table 135. VITech Company Information
Table 136. VITech Business Overview
Table 137. VITech Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 138. VITech Digital Chronic Disease Management Product Portfolio
Table 139. VITech Recent Developments
Table 140. ClouDr Group Company Information
Table 141. ClouDr Group Business Overview
Table 142. ClouDr Group Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 143. ClouDr Group Digital Chronic Disease Management Product Portfolio
Table 144. ClouDr Group Recent Developments
Table 145. JD Health Company Information
Table 146. JD Health Business Overview
Table 147. JD Health Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 148. JD Health Digital Chronic Disease Management Product Portfolio
Table 149. JD Health Recent Developments
Table 150. Ali Health Company Information
Table 151. Ali Health Business Overview
Table 152. Ali Health Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 153. Ali Health Digital Chronic Disease Management Product Portfolio
Table 154. Ali Health Recent Developments
Table 155. Ping An Good Doctor Company Information
Table 156. Ping An Good Doctor Business Overview
Table 157. Ping An Good Doctor Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 158. Ping An Good Doctor Digital Chronic Disease Management Product Portfolio
Table 159. Ping An Good Doctor Recent Developments
Table 160. We Doctor Group Company Information
Table 161. We Doctor Group Business Overview
Table 162. We Doctor Group Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 163. We Doctor Group Digital Chronic Disease Management Product Portfolio
Table 164. We Doctor Group Recent Developments
Table 165. Wei Mai Company Information
Table 166. Wei Mai Business Overview
Table 167. Wei Mai Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 168. Wei Mai Digital Chronic Disease Management Product Portfolio
Table 169. Wei Mai Recent Developments
Table 170. Medlinker Company Information
Table 171. Medlinker Business Overview
Table 172. Medlinker Revenue in Digital Chronic Disease Management Business (2021-2026) & (US$ Million)
Table 173. Medlinker Digital Chronic Disease Management Product Portfolio
Table 174. Medlinker Recent Developments
Table 175. Authors List of This Report
List of Figures
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. Digital Chronic Disease Management Product Image
Figure 5. Global Digital Chronic Disease Management Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
Figure 6. Global Digital Chronic Disease Management Market Share by Type: 2025 VS 2032
Figure 7. Charge Product
Figure 8. Free Product
Figure 9. Global Digital Chronic Disease Management Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million)
Figure 10. Global Digital Chronic Disease Management Market Share by Application: 2025 VS 2032
Figure 11. Medical Institutions Product
Figure 12. Pharmacy Product
Figure 13. Chronic Disease Patients Product
Figure 14. Global Digital Chronic Disease Management Market Size (US$ Million), Year-over-Year: 2021-2032
Figure 15. Global Digital Chronic Disease Management Market Size, (US$ Million), 2021 VS 2025 VS 2032
Figure 16. Global Digital Chronic Disease Management Market Share by Region: 2025 VS 2032
Figure 17. Global Digital Chronic Disease Management Market Share by Players in 2025
Figure 18. Global Digital Chronic Disease Management Manufacturers Established Date
Figure 19. Global Top 5 and 10 Digital Chronic Disease Management Players Market Share by Revenue in 2025
Figure 20. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025
Figure 21. North America Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 22. North America Digital Chronic Disease Management Market Share by Country (2021-2032)
Figure 23. United States Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 24. Canada Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 25. Mexico Digital Chronic Disease Management Market Share by Country (2021-2032)
Figure 26. Europe Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 27. Europe Digital Chronic Disease Management Market Share by Country (2021-2032)
Figure 28. Germany Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 29. France Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 30. U.K. Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 31. Italy Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 32. Spain Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 33. Russia Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 34. Netherlands Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 35. Nordic Countries Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 36. Asia-Pacific Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 37. Asia-Pacific Digital Chronic Disease Management Market Share by Country (2021-2032)
Figure 38. China Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 39. Japan Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 40. South Korea Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 41. India Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 42. India Digital Chronic Disease Management Market Share by Country (2021-2032)
Figure 43. Australia Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 44. China Taiwan Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 45. Southeast Asia Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 46. South America Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 47. South America Digital Chronic Disease Management Market Share by Country (2021-2032)
Figure 48. Brazil Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 49. Argentina Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 50. Chile Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 51. Colombia Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 52. Peru Digital Chronic Disease Management Market Size YoY Growth (2021-2032) & (US$ Million)
Figure 53. S3 Connected Health Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 54. WellDoc Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 55. AstraZeneca Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 56. NTT DATA Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 57. Credo Health Services Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 58. Dawn Health Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 59. Bayer Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 60. Medtronic Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 61. Teladoc Health Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 62. ScienceSoft Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 63. TriZetto Healthcare (Cognizant) Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 64. Omada Health Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 65. Phable Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 66. Pack Health Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 67. Epic Systems Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 68. Pathmate Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 69. EveryDose Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 70. Aptar Digital Health Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 71. VITech Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 72. ClouDr Group Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 73. JD Health Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 74. Ali Health Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 75. Ping An Good Doctor Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 76. We Doctor Group Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 77. Wei Mai Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Figure 78. Medlinker Revenue Growth Rate in Digital Chronic Disease Management Business (2021-2026)
Scope & coverage.
Types
- Charge
- Free
Applications
- Medical Institutions
- Pharmacy
- Chronic Disease Patients
Companies covered
- S3 Connected Health
- WellDoc
- AstraZeneca
- NTT DATA
- Credo Health Services
- Dawn Health
- Bayer
- Medtronic
- Teladoc Health
- ScienceSoft
- TriZetto Healthcare (Cognizant)
- Omada Health
- Phable
- Pack Health
- Epic Systems
- Pathmate
- EveryDose
- Aptar Digital Health
- VITech
- ClouDr Group
- JD Health
- Ali Health
- Ping An Good Doctor
- We Doctor Group
- Wei Mai
- Medlinker
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Digital Chronic Disease Management by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Charge
- 2.2.3 Free
- 2.3 Digital Chronic Disease Management by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Medical Institutions
- 2.3.3 Pharmacy
- 2.3.4 Chronic Disease Patients
- 2.4 Assumptions and Limitations
3 Digital Chronic Disease Management Breakdown Data by Type
- 3.1 Global Digital Chronic Disease Management Historic Market Size by Type (2021-2026)
- 3.2 Global Digital Chronic Disease Management Forecasted Market Size by Type (2027-2032)
4 Digital Chronic Disease Management Breakdown Data by Application
- 4.1 Global Digital Chronic Disease Management Historic Market Size by Application (2021-2026)
- 4.2 Global Digital Chronic Disease Management Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Digital Chronic Disease Management Market Perspective (2021-2032)
- 5.2 Global Digital Chronic Disease Management Growth Trends by Region
- 5.2.1 Global Digital Chronic Disease Management Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Digital Chronic Disease Management Historic Market Size by Region (2021-2026)
- 5.2.3 Digital Chronic Disease Management Forecasted Market Size by Region (2027-2032)
- 5.3 Digital Chronic Disease Management Market Dynamics
- 5.3.1 Digital Chronic Disease Management Industry Trends
- 5.3.2 Digital Chronic Disease Management Market Drivers
- 5.3.3 Digital Chronic Disease Management Market Challenges
- 5.3.4 Digital Chronic Disease Management Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Digital Chronic Disease Management Players by Revenue
- 6.1.1 Global Top Digital Chronic Disease Management Players by Revenue (2021-2026)
- 6.1.2 Global Digital Chronic Disease Management Revenue Market Share by Players (2021-2026)
- 6.2 Global Digital Chronic Disease Management Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Digital Chronic Disease Management Head Office and Area Served
- 6.4 Global Digital Chronic Disease Management Players, Product Type & Application
- 6.5 Global Digital Chronic Disease Management Manufacturers Established Date
- 6.6 Global Digital Chronic Disease Management Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Digital Chronic Disease Management Market Size (2021-2032)
- 7.2 North America Digital Chronic Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Digital Chronic Disease Management Market Size by Country (2021-2026)
- 7.4 North America Digital Chronic Disease Management Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Digital Chronic Disease Management Market Size (2021-2032)
- 8.2 Europe Digital Chronic Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Digital Chronic Disease Management Market Size by Country (2021-2026)
- 8.4 Europe Digital Chronic Disease Management Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Digital Chronic Disease Management Market Size (2021-2032)
- 9.2 Asia-Pacific Digital Chronic Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Digital Chronic Disease Management Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Digital Chronic Disease Management Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Digital Chronic Disease Management Market Size (2021-2032)
- 10.2 South America Digital Chronic Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Digital Chronic Disease Management Market Size by Country (2021-2026)
- 10.4 South America Digital Chronic Disease Management Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Digital Chronic Disease Management Market Size (2021-2032)
- 11.2 Middle East & Africa Digital Chronic Disease Management Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Digital Chronic Disease Management Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Digital Chronic Disease Management Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 S3 Connected Health
- 12.1.1 S3 Connected Health Company Information
- 12.1.2 S3 Connected Health Business Overview
- 12.1.3 S3 Connected Health Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.1.4 S3 Connected Health Digital Chronic Disease Management Product Portfolio
- 12.1.5 S3 Connected Health Recent Developments
- 12.2 WellDoc
- 12.2.1 WellDoc Company Information
- 12.2.2 WellDoc Business Overview
- 12.2.3 WellDoc Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.2.4 WellDoc Digital Chronic Disease Management Product Portfolio
- 12.2.5 WellDoc Recent Developments
- 12.3 AstraZeneca
- 12.3.1 AstraZeneca Company Information
- 12.3.2 AstraZeneca Business Overview
- 12.3.3 AstraZeneca Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.3.4 AstraZeneca Digital Chronic Disease Management Product Portfolio
- 12.3.5 AstraZeneca Recent Developments
- 12.4 NTT DATA
- 12.4.1 NTT DATA Company Information
- 12.4.2 NTT DATA Business Overview
- 12.4.3 NTT DATA Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.4.4 NTT DATA Digital Chronic Disease Management Product Portfolio
- 12.4.5 NTT DATA Recent Developments
- 12.5 Credo Health Services
- 12.5.1 Credo Health Services Company Information
- 12.5.2 Credo Health Services Business Overview
- 12.5.3 Credo Health Services Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.5.4 Credo Health Services Digital Chronic Disease Management Product Portfolio
- 12.5.5 Credo Health Services Recent Developments
- 12.6 Dawn Health
- 12.6.1 Dawn Health Company Information
- 12.6.2 Dawn Health Business Overview
- 12.6.3 Dawn Health Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.6.4 Dawn Health Digital Chronic Disease Management Product Portfolio
- 12.6.5 Dawn Health Recent Developments
- 12.7 Bayer
- 12.7.1 Bayer Company Information
- 12.7.2 Bayer Business Overview
- 12.7.3 Bayer Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.7.4 Bayer Digital Chronic Disease Management Product Portfolio
- 12.7.5 Bayer Recent Developments
- 12.8 Medtronic
- 12.8.1 Medtronic Company Information
- 12.8.2 Medtronic Business Overview
- 12.8.3 Medtronic Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.8.4 Medtronic Digital Chronic Disease Management Product Portfolio
- 12.8.5 Medtronic Recent Developments
- 12.9 Teladoc Health
- 12.9.1 Teladoc Health Company Information
- 12.9.2 Teladoc Health Business Overview
- 12.9.3 Teladoc Health Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.9.4 Teladoc Health Digital Chronic Disease Management Product Portfolio
- 12.9.5 Teladoc Health Recent Developments
- 12.10 ScienceSoft
- 12.10.1 ScienceSoft Company Information
- 12.10.2 ScienceSoft Business Overview
- 12.10.3 ScienceSoft Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.10.4 ScienceSoft Digital Chronic Disease Management Product Portfolio
- 12.10.5 ScienceSoft Recent Developments
- 12.11 TriZetto Healthcare (Cognizant)
- 12.11.1 TriZetto Healthcare (Cognizant) Company Information
- 12.11.2 TriZetto Healthcare (Cognizant) Business Overview
- 12.11.3 TriZetto Healthcare (Cognizant) Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.11.4 TriZetto Healthcare (Cognizant) Digital Chronic Disease Management Product Portfolio
- 12.11.5 TriZetto Healthcare (Cognizant) Recent Developments
- 12.12 Omada Health
- 12.12.1 Omada Health Company Information
- 12.12.2 Omada Health Business Overview
- 12.12.3 Omada Health Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.12.4 Omada Health Digital Chronic Disease Management Product Portfolio
- 12.12.5 Omada Health Recent Developments
- 12.13 Phable
- 12.13.1 Phable Company Information
- 12.13.2 Phable Business Overview
- 12.13.3 Phable Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.13.4 Phable Digital Chronic Disease Management Product Portfolio
- 12.13.5 Phable Recent Developments
- 12.14 Pack Health
- 12.14.1 Pack Health Company Information
- 12.14.2 Pack Health Business Overview
- 12.14.3 Pack Health Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.14.4 Pack Health Digital Chronic Disease Management Product Portfolio
- 12.14.5 Pack Health Recent Developments
- 12.15 Epic Systems
- 12.15.1 Epic Systems Company Information
- 12.15.2 Epic Systems Business Overview
- 12.15.3 Epic Systems Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.15.4 Epic Systems Digital Chronic Disease Management Product Portfolio
- 12.15.5 Epic Systems Recent Developments
- 12.16 Pathmate
- 12.16.1 Pathmate Company Information
- 12.16.2 Pathmate Business Overview
- 12.16.3 Pathmate Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.16.4 Pathmate Digital Chronic Disease Management Product Portfolio
- 12.16.5 Pathmate Recent Developments
- 12.17 EveryDose
- 12.17.1 EveryDose Company Information
- 12.17.2 EveryDose Business Overview
- 12.17.3 EveryDose Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.17.4 EveryDose Digital Chronic Disease Management Product Portfolio
- 12.17.5 EveryDose Recent Developments
- 12.18 Aptar Digital Health
- 12.18.1 Aptar Digital Health Company Information
- 12.18.2 Aptar Digital Health Business Overview
- 12.18.3 Aptar Digital Health Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.18.4 Aptar Digital Health Digital Chronic Disease Management Product Portfolio
- 12.18.5 Aptar Digital Health Recent Developments
- 12.19 VITech
- 12.19.1 VITech Company Information
- 12.19.2 VITech Business Overview
- 12.19.3 VITech Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.19.4 VITech Digital Chronic Disease Management Product Portfolio
- 12.19.5 VITech Recent Developments
- 12.20 ClouDr Group
- 12.20.1 ClouDr Group Company Information
- 12.20.2 ClouDr Group Business Overview
- 12.20.3 ClouDr Group Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.20.4 ClouDr Group Digital Chronic Disease Management Product Portfolio
- 12.20.5 ClouDr Group Recent Developments
- 12.21 JD Health
- 12.21.1 JD Health Company Information
- 12.21.2 JD Health Business Overview
- 12.21.3 JD Health Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.21.4 JD Health Digital Chronic Disease Management Product Portfolio
- 12.21.5 JD Health Recent Developments
- 12.22 Ali Health
- 12.22.1 Ali Health Company Information
- 12.22.2 Ali Health Business Overview
- 12.22.3 Ali Health Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.22.4 Ali Health Digital Chronic Disease Management Product Portfolio
- 12.22.5 Ali Health Recent Developments
- 12.23 Ping An Good Doctor
- 12.23.1 Ping An Good Doctor Company Information
- 12.23.2 Ping An Good Doctor Business Overview
- 12.23.3 Ping An Good Doctor Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.23.4 Ping An Good Doctor Digital Chronic Disease Management Product Portfolio
- 12.23.5 Ping An Good Doctor Recent Developments
- 12.24 We Doctor Group
- 12.24.1 We Doctor Group Company Information
- 12.24.2 We Doctor Group Business Overview
- 12.24.3 We Doctor Group Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.24.4 We Doctor Group Digital Chronic Disease Management Product Portfolio
- 12.24.5 We Doctor Group Recent Developments
- 12.25 Wei Mai
- 12.25.1 Wei Mai Company Information
- 12.25.2 Wei Mai Business Overview
- 12.25.3 Wei Mai Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.25.4 Wei Mai Digital Chronic Disease Management Product Portfolio
- 12.25.5 Wei Mai Recent Developments
- 12.26 Medlinker
- 12.26.1 Medlinker Company Information
- 12.26.2 Medlinker Business Overview
- 12.26.3 Medlinker Revenue in Digital Chronic Disease Management Business (2021-2026)
- 12.26.4 Medlinker Digital Chronic Disease Management Product Portfolio
- 12.26.5 Medlinker Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
$2,950USD
Buy nowPDF by email within 3–5 working days after payment confirmation.
Talk to an analyst